A CNI-Free, Everolimus Based Regimen in De-Novo Heart Transplant Recipients Increases Albuminuria But Improves Glomerular Filtration Rate Compared With Conventional Immunosuppression

被引：0
|
作者：
Gustafsson, E. [1 ]
Andreassen, A. [2 ]
Arora, S. [2 ]
Andersson, B. [3 ]
Gude, E. [2 ]
Eiskjaer, H. [4 ]
Raadegran, G. [5 ]
Dellgren, G. [6 ]
Gullestad, L. [2 ]
机构：
[1] Rigshosp, Dept Cardiol, DK-2100 Copenhagen, Denmark
[2] Univ Oslo, Rikshosp, Dept Cardiol, N-0027 Oslo, Norway
[3] Sahlgrens Univ Hosp, Dept Cardiol, Gothenburg, Sweden
[4] Skejby Univ Hosp, Dept Cardiol, Aarhus, Denmark
[5] Skaane Univ Hosp, Dept Cardiol, Lund, Sweden
[6] Sahlgrens Univ Hosp, Dept Cardiac Surg, Gothenburg, Sweden
来源：
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2014年 / 33卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
771
引用
收藏
页码：S281 / S281
页数：1
相关论文
共 32 条
  • [11] An open, single centre, prospective study to investigate a steroid free immunosuppressive regimen for de novo renal transplant recipients followed by a two arm randomisation to a CNI-sparing and a CNI-free maintenance immunosuppression after 3 months
    Oetti, T.
    Descoeudres, B.
    Burkhalter, F.
    Bachmann, A.
    Guerke, L.
    Mihatsch, M. J.
    Dickenmann, M.
    Steiger, J.
    SWISS MEDICAL WEEKLY, 2008, 138 (47-48) : 15S - 15S
  • [12] DE NOVO EVEROLIMUS- VERSUS MMF-BASED IMMUNOSUPPRESSION IN HEART TRANSPLANT RECIPIENTS: EFFECT ON PROTEINURIA
    Andreassen, A.
    Rinaldi, M.
    Gerosa, G.
    Bara, C.
    Dong, G.
    Lopez, P.
    Segovia, J.
    TRANSPLANT INTERNATIONAL, 2011, 24 : 66 - 66
  • [13] Everolimus-based immunosuppression in de novo heart transplant recipients:: Impact on wound healing and tissue regeneration
    Zuckermann, Andreas
    Arizon, Jose
    Wang, Shoei-Sheng
    Vigano, Mario
    Maccherini, Massimo
    Vermes, Emmanuelle
    Bara, Christoph
    Ross, Heather
    Laufer, Guenther
    Lehmkuhl, Hans
    Keogh, Anne M.
    Sips, Carole D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 571 - 571
  • [14] Long-term Effect on Albuminuria and Glomerular Filtration Rate of a Calcineurin Inhibitor-Free Everolimus Based Immunosuppressive Regimen after Heart Transplantation
    Nelson, L. M.
    Andreassen, A. K.
    Andersson, B.
    Gude, E.
    Eiskjaer, H.
    Raadegran, G.
    Dellgren, G.
    Gullestad, L.
    Gustafsson, F.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2016, 35 (04): : S280 - S280
  • [15] Blood Pressure in De Novo Heart Transplant Recipients Treated With Everolimus Compared With a Cyclosporine-based Regimen: Results From the Randomized SCHEDULE Trial
    Andreassen, Arne K.
    Broch, Kaspar
    Eiskjaer, Hans
    Karason, Kristjan
    Gude, Einar
    Molbak, Dorte
    Stueflotten, Wenche
    Gullestad, Lars
    TRANSPLANTATION, 2019, 103 (04) : 781 - 788
  • [16] Everolimus immunosuppression for renal protection, reduction of allograft vasculopathy and prevention of allograft rejection in de-novo heart transplant recipients: could we have it all?
    Gude, Einar
    Gullestad, Lars
    Andreassen, Arne K.
    CURRENT OPINION IN ORGAN TRANSPLANTATION, 2017, 22 (03) : 198 - 206
  • [17] Treatment of De Novo Renal Transplant Recipients With Calcineurin Inhibitor-free, Belatacept Plus Everolimus-based Immunosuppression
    Peddi, V. Ram
    Marder, Bradley
    Gaite, Luis
    Oberholzer, Jose
    Goldberg, Ryan
    Pearson, Thomas
    Yang, Harold
    Allamassey, Lisa
    Polinsky, Martin
    Formica, Richard N.
    TRANSPLANTATION DIRECT, 2023, 9 (02): : E1419
  • [18] CMV Infections Are Less Frequent in De Novo Heart Transplant Recipients Receiving Immunosuppression with Everolimus Plus Reduced CsA Compared to MMF and Standard CsA
    Kobashigawa, J.
    Ross, H.
    Kfoury, A. G.
    Van Bakel, A.
    Ewald, G.
    Burton, J.
    Andreassen, A.
    Banchs, H. L.
    Segovia, J.
    Lopez, P.
    Cines, M.
    Dong, G.
    Potena, L.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 131 - 132
  • [19] CMV INFECTIONS ARE LESS FREQUENT IN DE NOVO HEART TRANSPLANT RECIPIENTS RECEIVING IMMUNOSUPPRESSION WITH EVEROLIMUS PLUS REDUCED CSA COMPARED TO MMF AND STANDARD CSA
    Schulz, U.
    Kobashigawa, J.
    Bara, C.
    Hirt, S.
    Lehmkuhl, H. B.
    Lopez, P.
    Costard-Jaeckle, A.
    TRANSPLANT INTERNATIONAL, 2011, 24 : 22 - 22
  • [20] Prospective, randomized, multicenter trial comparing conversion to a CNI-free regimen (MMF & sirolimus) vs. a CNI-reduced, MMF-based immunosuppression to improve renal function in late cardiac transplant recipients
    Groetzner, J.
    Schulz, U.
    Kaczmarek, I.
    Stegemann, E.
    Kaiser, K.
    Voss, M.
    Wittwer, T.
    Wahlers, T. H.
    Schirmer, J.
    Sohn, H. Y.
    Welp, H.
    Schmid, C.
    Meiser, B.
    Reichart, B.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2007, 26 (02): : S229 - S229
1234